{"schema_version":"4ort.packet/1","entity":{"entity_id":"precision-bayesian-phase-iii-dosefinding-based-on-utilities-tailored-to-prognostic-subgroups","kg_uuid":"3ec68809-7293-488f-9e80-55e6aeb9a185","wikidata_id":"openalex:W3180122786","name":"Precision Bayesian phase I‐II dose‐finding based on utilities tailored to prognostic subgroups","description":"Research article (Statistics in Medicine, 2021) · cited 22× · AI/ML","type":"CreativeWork","url":"https://4ort.xyz/entity/precision-bayesian-phase-iii-dosefinding-based-on-utilities-tailored-to-prognostic-subgroups"},"status":"complete","as_of":{"copy_written_at":"2026-10-20T02:03:47Z","last_source_edit_seen":null,"stale_possible":false,"claims_refreshed_at":null,"source_revision":null},"facts":[{"field":"P31","label":"instance of","value":"scholarly article","value_id":"Q13442814","value_raw":"Q13442814","rank":"normal","current":null,"qualifiers":[],"layer":"source","citation":{"source":"openalex","source_name":"OpenAlex","source_record":"https://openalex.org/W3180122786","source_edition":null,"edition_basis":"unknown","licence":"CC0 1.0 Universal","licence_url":"https://creativecommons.org/publicdomain/zero/1.0/","attribution":null,"references":[]},"trust":{"band":"high","basis":"dataset-record/1","calibrated":false}},{"field":"P577","label":"publication date","value":"2021-07-09","value_id":null,"value_raw":"+2021-07-09T00:00:00Z","rank":"normal","current":null,"qualifiers":[],"layer":"source","citation":{"source":"openalex","source_name":"OpenAlex","source_record":"https://openalex.org/W3180122786","source_edition":"20260923","edition_basis":"lake_edition","licence":"CC0 1.0 Universal","licence_url":"https://creativecommons.org/publicdomain/zero/1.0/","attribution":null,"references":[]},"trust":{"band":"high","basis":"dataset-record/1","calibrated":false}},{"field":"P356","label":"DOI","value":"10.1002/SIM.9120","value_id":null,"value_raw":"10.1002/SIM.9120","rank":"normal","current":null,"qualifiers":[],"layer":"source","citation":{"source":"openalex","source_name":"OpenAlex","source_record":"https://openalex.org/W3180122786","source_edition":"20260923","edition_basis":"lake_edition","licence":"CC0 1.0 Universal","licence_url":"https://creativecommons.org/publicdomain/zero/1.0/","attribution":null,"references":[]},"trust":{"band":"high","basis":"dataset-record/1","calibrated":false}},{"field":"P698","label":"PubMed publication ID","value":"34636054","value_id":null,"value_raw":"34636054","rank":"normal","current":null,"qualifiers":[],"layer":"source","citation":{"source":"openalex","source_name":"OpenAlex","source_record":"https://openalex.org/W3180122786","source_edition":"20260923","edition_basis":"lake_edition","licence":"CC0 1.0 Universal","licence_url":"https://creativecommons.org/publicdomain/zero/1.0/","attribution":null,"references":[]},"trust":{"band":"high","basis":"dataset-record/1","calibrated":false}},{"field":"P859","label":"sponsor","value":"National Science Foundation","value_id":"Q304878","value_raw":"Q304878","rank":"normal","current":null,"qualifiers":[],"layer":"source","citation":{"source":"openalex","source_name":"OpenAlex","source_record":"https://openalex.org/W3180122786","source_edition":"20260923","edition_basis":"lake_edition","licence":"CC0 1.0 Universal","licence_url":"https://creativecommons.org/publicdomain/zero/1.0/","attribution":null,"references":[]},"trust":{"band":"high","basis":"dataset-record/1","calibrated":false}},{"field":"P1433","label":"published in","value":"Statistics in Medicine","value_id":"Q7604438","value_raw":"Q7604438","rank":"normal","current":null,"qualifiers":[],"layer":"source","citation":{"source":"openalex","source_name":"OpenAlex","source_record":"https://openalex.org/W3180122786","source_edition":"20260923","edition_basis":"lake_edition","licence":"CC0 1.0 Universal","licence_url":"https://creativecommons.org/publicdomain/zero/1.0/","attribution":null,"references":[]},"trust":{"band":"high","basis":"dataset-record/1","calibrated":false}},{"field":"P1476","label":"title","value":"Precision Bayesian phase I‐II dose‐finding based on utilities tailored to prognostic subgroups","value_id":null,"value_raw":{"lang":"en","text":"Precision Bayesian phase I‐II dose‐finding based on utilities tailored to prognostic subgroups"},"rank":"normal","current":null,"qualifiers":[],"layer":"source","citation":{"source":"openalex","source_name":"OpenAlex","source_record":"https://openalex.org/W3180122786","source_edition":"20260923","edition_basis":"lake_edition","licence":"CC0 1.0 Universal","licence_url":"https://creativecommons.org/publicdomain/zero/1.0/","attribution":null,"references":[]},"trust":{"band":"high","basis":"dataset-record/1","calibrated":false}}],"unknowns":[],"omitted":{"facts":0,"reason":null},"licences":[{"source":"openalex","source_name":"OpenAlex","licence":"CC0 1.0 Universal","licence_url":"https://creativecommons.org/publicdomain/zero/1.0/","attribution":null,"fields":["P31","P577","P356","P698","P859","P1433","P1476"]}],"routes":{"entity_page":"https://4ort.xyz/entity/precision-bayesian-phase-iii-dosefinding-based-on-utilities-tailored-to-prognostic-subgroups","packet_api":"https://4ort.xyz/api/v1/entities/precision-bayesian-phase-iii-dosefinding-based-on-utilities-tailored-to-prognostic-subgroups/packet","facts_jsonld":"https://4ort.xyz/entity/precision-bayesian-phase-iii-dosefinding-based-on-utilities-tailored-to-prognostic-subgroups/facts.json","changes_api":"https://4ort.xyz/api/v1/knowledge/get_entity_changes?entity=precision-bayesian-phase-iii-dosefinding-based-on-utilities-tailored-to-prognostic-subgroups","attention_api":"https://4ort.xyz/api/v1/knowledge/get_attention?entity=precision-bayesian-phase-iii-dosefinding-based-on-utilities-tailored-to-prognostic-subgroups","wikidata":null,"official_website":null},"trust_rules":{"dataset-record/1":"The fact is the cited dataset's own published record (band high). Reference support, not a probability."},"notes":[]}